The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at info@ihe.ca. Thank you!
Refine your search by clicking filters to the left.
1st International Conference on FASD Prevention 23 – 25 September 2013 IHE hosted the First International Conference on Prevention of FASD, September 23 - 25, 2013 in Edmonton, Alberta. More than 800 people were in attendance, including global experts and leaders in the health system, government, and the academic and business communities. Event Link | The International…
Primary Care Low Back Exam factsheet - 2006. Extracted from the Chronic Pain Management Binder November 2005. Link to Alberta Ambassador Guideline Adaptation Program
Overview Conducting the Event The conferences usually involve 15 or more experts who deliver the scientific evidence and testimony around 5-8 specific questions on a particular health subject. They deliver this evidence to a jury of 12-15 people over two days in front of an audience of 300+ people. The consensus format provides an independent look at issues from an unbiased panel.…
Fetal Alcohol Spectrum Disorder (FASD) is caused by alcohol use during pregnancy. No amount of alcohol is known to be safe for an unborn child at any stage in its development. Alcohol consumed by the mother during pregnancy easily crosses the placenta and can cause a range of developmental defects that result in both physical diseases and intellectual disabilities. In particular,…
Ongoing research and evaluation of programs will help to determine best practices for preventing FASD and supporting those already affected. The Government of Alberta's Fetal Alcohol Spectrum Disorder Cross-ministry Committee has a comprehensive website with extensive resources on FASD. Visit their site at http://fasd.alberta.ca/ or select from the links below for FASD research…
This consensus development conference was commissioned by the Government of Alberta to improve the transition of its system of care for people with severe and persistent mental illness (SPMI) toward the community. The system, previously hospital- and institution-centred, is moving towards becoming a community-centred, patient- and family-led one. The development and deployment…
À titre de président du jury, le Dr Alain Lesage, M.D., FRCPC, M.Phil., DFAPA, professeur au département de psychiatrie de l'Université de Montréal et clinicien à l’Institut universitaire en santé mentale de Montréal, Québec, a dirigé un comité spécial dont le mandat était d'élaborer…
The IHE began doing research and engaged in knowledge transfer activities in the field of FASD in 2008. Since then the Institute has hosted several events and researchers at the Institute have developed more than 25 publications, of which 10 are published in peer reviewed journals.
Clinical Resources | Patient Resources Clinical Practice Guideline Primary Care Management of Headache in Adults (2nd edition September 2016) Guideline Documents including Full Guideline hosted by Towards Optimized Practice (TOP) Albertahttp://www.topalbertadoctors.org/cpgs/10065 Supporting Documents and Process Description Background Document, 2nd Edition.2nd Edition Coming…
Clinical Resources | Patient Resources Clinical Practice Guideline Evidence-Informed Primary Care Management of Low Back Pain(3rd edition, December 2015) Guideline Documents including Full Guideline hosted by Towards Optimized Practice (TOP) Albertahttp://www.topalbertadoctors.org/cpgs/885801 Supporting Documents and Process Description Background Document, 3rd Edition.…
INTRODUCTION: The objective of this study was to determine the short-term cost impact thatmedical tourism for bariatric surgery has on a public healthcare system. Due to long wait times for bariatric surgery services, Canadians are venturing to private clinics in other provinces/countries. Postoperative care in this population not only burdens the provincial health system…
Changing how Alberta pays for health care is critical to improve value, achieve better quality, and slow cost growth. There is need in Alberta for capacity in applied economics knowledge to enhance economic surveillance that is independent from government, but supports ongoing provincial development of the organizational and incentive structures for funding the health service delivery…
As our name implies, health economics is a core component of what we do. The Institute provides economic analysis at both the system level (in broad areas of health-sector management and significant disease burdens such as cancer and mental health) as well as economic evaluation of individual technologies and therapeutic interventions. We study health economics and…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development…
In December 2008, the IHE launched a series of semi-annual innovation forums whose goal is to bring together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system, not just in Alberta, but to all of Canada and the international community, as well. Details of each session are available by selecting the appropriate link.…
IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. Included in this portfolio is the IHE's well-regarded Consensus Development Conference Series, which has seen us host international events on Fetal Alcohol Spectrum Disorder and Depression in…
Promoting the use of evidence to encourage and support best practice in pain management The Alberta Ambassador Guideline Adaptation Program started in 2004 as a knowledge translation (KT) strategy for promoting the use of research evidence to encourage and support best practice in primary care across the province. The Program is an active collaboration of individuals and agencies…
Informed Decision-Making for Health Established by the Alberta Ministry of Health in 1994, the HTA Program has been part of the Institute of Health Economics (IHE) since 2006. The Program’s expertise is unique in Canada, with a multidisciplinary staff including experts in general medicine, epidemiology, biomedical engineering, biostatistics, health economics, health services…
Chair Dr. Lorne Tyrrell, Director, Li Ka Shing Institute of Virology, University of Alberta Government and Public Authorities Mr. Justin Riemer, Assistant Deputy Minister, Alberta Health Mr. Jason Krips, Deputy Minister, Economic Development and Trade Mr. Reg Joseph, Vice President, Health, Alberta Innovates Dr. Kathryn Todd, Vice-President Research Innovation & Analytics,…
Academic University of Alberta http://www.ualberta.ca/ The U of A is a leader in research. Our campuses attract professors with international reputations and connections - leaders who are interested in making a difference in the world. At the U of A, the brightest minds in the arts, humanities and sciences gather, putting their expertise to work in the classroom and in the community.…
The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
The IHE is frequently requested to be a partner on academic grant applications and policy initiatives with other organizations. In particular we are often the economic analysis partner or knowledge transfer partner for other organizations. Recent grant proposals, on which we are partners, include: Development, Implementation and Evaluation of the Impact of a Choosing Wisely List…
In November 2014, the Institute of Health Economics partnered with Eli Lilly Canada Inc. and the Canadian Institutes of Health Research’s Institute for Health Services and Policy Research to hold a roundtable to discuss the federal role in healthcare innovation. The roundtable aimed to examine the existing state of healthcare innovation, its strengths and weaknesses (or gaps),…
Speaker Biographies Keynote Speakers Dr. Andreas LaupacisChair, Health Quality Ontario Dr. Laupacis is a general internist and the Executive Director of the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He is a Professor at the University of Toronto in both the Department of Medicine and the Institute of Health Policy, Management and Evaluation. Dr. Laupacis…
27 November 2014Edmonton, Alberta Welcome and Greetings from the Minister of Health WelcomeDr. Lorne Tyrrell, Chair, Institute of Health Economicshttp://vimeo.com/channels/907291/113749308 Greetings from the ProvinceGlenn Monteith, Chief Delivery Officer, Alberta Healthhttp://vimeo.com/channels/907291/113749310 Keynote presentations Health System Standards: From Good Intent to…
27 November 2014 Edmonton, Alberta Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XII – Health System Standards: From Good Intent to Real World…
Health System Standards: From Good Intent to Real World Application is the 12th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
Click HERE for all information relating to our past events including videos, presentations, conference programs, and more!
The Institute of Health EconomicsCredits: FASD Research Team - Alberta Innovates; Music - Ben Sound What we do The Institute of Health Economics (IHE) is a not-for-profit organization with key competencies in: Health economics & decision analytic modeling Health technology assessment Knowledge Transfer/Exchange Core objectives Support decision making in health policy…
IHE Timeline 1994 – The University of Alberta and the Government of Alberta establish a steering committee drawn from the universities of Alberta and Calgary, the Alberta Heritage Foundation for Medical Research, and the federal and provincial governments to explore the feasibility of creating an Alberta-based Institute of Pharmaco-Economics. 1995 – The Institute of…
Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference 23 November 2014 Edmonton, Alberta This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the…
PDF of a PowerPoint Presentation by Dr. Ken Butcher, WMC Health Sciences Centre, University of Alberta. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference In this 45 minute presentation, Dr. Butcher reviewed how to diagnose stroke and discussed the burden of Cardioembolic and Cryptogenic Stroke. He talked about the recent…
PDF of a PowerPoint Presentation by Dr. Thomas Jeerakathil, Associate Professor, University of Alberta; Co-physician lead, ASPIRE TIA Triaging Project, Northern Stroke Lead CV/S SCN. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference This presentation looked at the diagnosis of likely TIA syndromes and how to identify and…
PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…
This free forum for primary care clinicians was held in conjunction with the annual Accelerating Primary Care conference in Edmonton, Alberta, November 23, 2014. The forum saw three physician leaders review the latest developments in the continuously advancing field of stroke prevention and care, with a particular focus on the role of primary care. The forum was…
PDF of a PowerPoint Presentation by Dr. Blair O’Neill, Professor of Medicine, University of Alberta; Interventional Cardiologist, Mazankowski AHI; Senior Medical Director, CV Health and Stroke SCN, Alberta Health Services; Past President, Canadian Cardiovascular Society. Stroke Prevention and Management in Primary Care: a free forum at the Accelerating Primary Care Conference…
17 November 2014 Ottawa, Ontario The federal Ministry of Health (Health Canada) announced the creation of the Advisory Panel on Healthcare Innovation on June 24, 2014, to examine innovative health care ideas and approaches that exist in Canada and internationally. The Panel’s directive is to determine what approaches hold the greatest potential for Canadians and to create…
Monday, 17 November 2014 Ottawa, Ontario Opening and Opening Remarks Moderator: Mr. John Sproule, IHE Ms. Lauren Fisher, Eli Lilly Canada Inc. Mr. Glenn Brimacombe, Canadian Psyciatric Association Roundtable Discussion: What can the federal government do to promote and support innovation in the healthcare system? Overview of current state of healthcare innovation from a Federal…
Summary Report Health Innovation in Canada: Federal Role Roundtable: Summary ReportDownload Report Background Document Health Innovation in Canada: Federal Role Roundtable – BackgrounderDownload Background Document
The purpose of this roundtable was to gather a small, select group of thought leaders to engage in informed discourse, which was summarized in a report submitted to the new federal Healthcare Innovation Advisory Panel. This roundtable, created in response to the Federal Healthcare Innovation Advisory Panel’s call for stakeholder input, was an exciting opportunity to…
Objectives: To estimate the annual health services utilization (HSU) cost per person with FASD by sex and age; the lifetime HSU cost per person with FASD by sex, and the annual HSU cost of FASD for Alberta by sex.
BACKGROUND & AIMS: Infliximab is effective for induction and maintenance of response in patients with moderate to moderately severe ulcerative colitis. Previous cost analyses of infliximab treatment for ulcerative colitis used models of colectomy vs infliximab and response rates derived from early clinical trials. In real life, therapeutic options are more complex; patients…
PDF of a PowerPoint presentation by Dr. Jitender Sareen, MD, FRCPC. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Mr. David McDaid, BSC, MSc, MSc. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Heinz Katschnig, MD. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Elliot Goldner, MD, FRC(P), MHSc. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Antonio Lora, MD. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Luis Salvador-Carulla, MD, PhD. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Eric Latimer, PhD. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Carol Adair, MSc, PhD. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Mr. Steve Lurie, BA, MSW, MM. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Giovanni de Girolamo, MD, PhD. Consensus Development Conference on Improving Mental Health Transitions
4 – 6 November 2014 Edmonton, Alberta The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS), hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 – 6, 2014. Download Consensus Statement | Télécharger…
Speakers | Jury | Scientific Committee | Planning Committee Scientific Chair Roger Bland, CM, MB, ChB, FRCPC, FRCPsych Chair, Scientific Committee; Professor Emeritus, Department of Psychiatry, University of Alberta, Edmonton, Alberta Speakers Carol Adair, MSc, PhD Researcher, Psychiatric Epidemiologist and Associate Professor,…
Program Consensus Development Conference on Improving Mental Health Transitions 2014 - Final ProgramDownload Program Consensus Statement Consensus Statement on Improving Mental Health Transitions 2014Download Consensus Statement Déclaration de consensus sur l'amélioration des transitions en santé mentaleTélécharger la déclaration de consensus…
Tues 4 Nov 2014 | Wed 5 Nov 2014 | Thu 6 Nov 2014 Improving Mental Health Transitions 2014 - Final Program Tuesday, 4 November 2014 08:00 – 08:45 Opening RemarksRoger Bland, CM, MB, ChB, FRCPC, FRCPsychhttp://vimeo.com/channels/839914/112193615 GreetingsCouncillor Scott McKeenhttp://vimeo.com/112193618 Opening Prayer from ElderGloria Lairdhttp://vimeo.com/112193614…
The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS) hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 - 6, 2014.
PDF of a PowerPoint presentation by Mr. Orrin Lyseng. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Linda Gask, MSc, PhD, FRCPsych, FRCGP. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Dan Cohen, MD, PhD. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Richard Warner, MD, DPM. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Mr. Gerrit van der Leer. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Philippa Garety, MA, MPhil, MA (Ed), PhD, FBPsS. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Thomas Becker, Dr. Med. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Thomas Raedler, MD. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Mr. Howard Sapers. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Tim Aubry, BA, MA, PhD. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Ms. Sara Lapsley, BA, MA (Candidate). Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Scott Patten, MD, FRCPC, PhD. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Oliver Mason, DPhil, DClinPsy. Consensus Development Conference on Improving Mental Health Transitions
PDF of a PowerPoint presentation by Dr. Roger Bland, CM, MB, ChB, FRCPC, FRCPsych. Consensus Development Conference on Improving Mental Health Transitions
2 November 2014 Toronto, Ontario In April 2014, we held the first roundtable discussion on the current and future role of real world evidence (RWE) in Canada, bringing together multiple stakeholders from across Canada and internationally. Workshop participants felt there was much more to explore in future discussion and a specific need was identified to focus part of future conversations…
Biographies Chris Henshall Health Economics Research Group (HERG), Brunel University Dr. Chris Henshall is an Honorary Professor at HERG and an independent consultant on health, research and innovation policy. Chris has held various academic and senior management positions in the health research system and the higher education system in the UK. He is an Associate Professor in the…
Sunday, 2 November 2014 Toronto, Ontario Opening and Opening Remarks John Sproule, IHE Lisa Marsden, VP of Market Access & Government Relations at AstraZeneca Canada Vasanthi Srinivasan, Executive Director, Ontario SPOR DSU PART I: Fit for purpose: When and where is real-world evidence most useful? Speaker: Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's…
Roundtable Final Report Roundtable on Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report – September 2014Download Roundtable Final Report Program Real World Evidence: Priority Setting for Action – How to best use health system data to improve health?Download Program
Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support Unit (Ontario) and AstraZeneca Canada. It was held in conjunction with the annual Canadian Association for Population Therapeutics (CAPT).…
Real World Evidence: System Readiness – Are we ready to use routinely collected data to improve health system performance? Summary Report Real World Evidence: Priority Setting for Action was an invitational roundtable discussion organized by the Institute of Health Economics (IHE) and supported by and developed in partnership with Strategy for Patient Oriented Research Support…
PDF of a PowerPoint presentation by Dr. Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's Hospital. Real World Evidence: Priority Setting for Action Roundtable
PDF of a PowerPoint presentation by Mr. Neil Corner, Director, Innovative Solutions (Real World Evidence Lead) at IMS Brogan. Real World Evidence: Priority Setting for Action Roundtable
Objectives: To estimate incidence and prevalence of FASD by sex and age in Alberta, Canada.
Abstract: Canadian and US health systems have often been characterized as having vastly different approaches to the financing and delivery of healthcare, with Canada portrayed as more reliant on rationing based on costs. In this article, we examine the similarities and differences between the two countries, the evolution and current role of health economic evaluation, and…
Welcome to our sitemap. From here you can navigate through the first level of our site.
Published quarterly by the KRP Tax Group, our newsletter provides up-to-date information regarding the latest tax rules and accounting principles. To subscribe to our electronic newsletter, please fill out the form below:
Institute of Health Economics Privacy Policy Your privacy is very important to us. Accordingly, we have developed this Policy in order for you to understand how we collect, use, communicate and disclose and make use of personal information. The following outlines our privacy policy. Before or at the time of collecting personal information, we will identify the purposes for which…
Subscribe to IHE Mailing List To subscribe to an IHE mailing list, please click the Subscriptions link. To unsubscribe from our mailing list at any time, please contact us at info@ihe.ca. Subscribe to IHE Mailing List General Inquiries The Institute of Health Economics welcomes your inquiries. If you wish to receive more information about any of our products or services,…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the clinical effectiveness and safety of hysteroscopic tubal sterilization, and the value for money associated with adopting hysteroscopic tubal sterilization in Alberta. Section Authors: Section One – Background and Context: Carmen…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an evidence assessment of the best available research evidence on the safety and effectiveness, cost effectiveness and budget impact of using Endovenous Laser Ablation (EVLA) or Endovenous Radiofrequency Ablation (RFA) in the management of symptomatic varicose…
OBJECTIVE: To provide Canadian estimates of health care utilization costs associated withrheumatoid arthritis (RA)-related and non-RA-related care within 4 treatment strategies and in different physical functioning categories.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the safety, screening accuracy, therapeutic efficacy, patient outcomes and cost effectiveness of first trimester Quad (1T-Quad) +/- NT and NIPT screening for fetal trisomies. Section Authors: Section One – Technology Effectiveness and Safety: Ken Bond,…
OBJECTIVE: Sustained remission in rheumatoid arthritis (RA) results in healthcare utilizationcost savings. We evaluated the variation in estimates of savings when different definitions ofremission [2011 American College of Rheumatology/European League Against Rheumatism Boolean Definition, Simplified Disease Activity Index (SDAI) ≤ 3.3, Clinical Disease Activity Index…
BACKGROUND: Interest in the well-being of physicians has increased because of their contributions to the healthcare system quality. There is growing recognition that physicians are exposed to workplace factors that increase the risk of work stress. Long-term exposure to high work stress can result in burnout. Reports from around the world suggest that about one-third to…
Summary of Systematic Reviews, Primary Studies, and Evidence-based Guidelines. The following research questions were addressed in this review: What are the clinical effects of a universal screening strategy for ARO carriage when compared with no screening? What are the clinical effects of a universal screening strategy for ARO carriage when compared with targeted screening (screening…
This discussion paper has been produced in response to a request from CIHR Institute of Health Services and Policy Research (CIHR IHSPR). The discussion paper will provide guidance to those tasked with conducting an economic evaluation of complex health system interventions. The guidance will be an elaboration of existing National guidelines for economic evaluation, and serve as…
Antibiotic-Resistant Organisms (AROs) are a serious health problem, though they are more prevalent in some settings than others. We were asked to make findings and develop recommendations on how to address surveillance of and screening for AROs in acute care hospitals. This consensus statement addresses these requests. However, confining the discussion and recommendations to hospitals…
PDF of a PowerPoint presentation by Dr. Elizabeth Bryce, BSc, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Daniel Gregson, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Lindsay Nicolle, BSc, BSc (med), MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Anthony Harris, MD, MPH. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPath. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Ms. Kim Neudorf. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Yves Longtin, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Trish Perl, MD, MSc. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Eli Perencevich, MD, MS. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Mark Loeb, BSc, MSc, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Serge Desnoyers, PhD. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
18 – 20 June 2014 Calgary, Alberta The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 – 20, 2014, was the first event of its kind to look at issues in the field of AROs. Download Consensus Statement The Consensus Conference model is an exciting format,…
Speakers | Jury | Scientific Committee | Organizing Committee Speakers Elizabeth Bryce, BSc, MD, FRCPCRegional Medical Director for Infection Control, Vancouver Coastal Health; Clinical Professor, University of British Columbia (UBC) Barry Cookson, BDS, MBBS, MSc, HonDipHIC, FRSPH, FRCP, FFPH, FRCPathProfessor, University College and London School…
Weds 18 June 2014 | Thurs 19 June 2014 | Fri 20 June 2014 Surveillance and Screening for Antimicrobial Resistant Organisms (AROs) 2014 - Final Program Wednesday, 18 June 2014 08:00 – 08:15 Opening RemarksDr. John Conly and Dr. James Talbothttp://vimeo.com/channels/910470/99417520 08:15 – 09:45 QUESTION 1: Overview a) What are AROs? What is their incidence…
Program Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) 2014 – Final ProgramDownload Program Consensus Statement Consensus Statement on Surveillance and Screening of AROs (Antimicrobial-Resistant Organisms)Download Consensus Statement Remarks from Jury Chair Remarks from the jury chair, Dr. Tom Marrie, Dean of…
PDF of a PowerPoint presentation by Dr. Pilar Ramon-Pardo, MD, PhD. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Howard Njoo, MD, MHSc. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Julian Davies, BSc, PhD, FRS. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Scott McEwen, DVM, DVSc, Dip ACVP. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Joel Kettner, MD, MSc, FRCSC, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Andrew Simor, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Robert Weinstein, MD. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. James Talbot, PhD, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. David Patrick, MD, FRCPC, MHSc. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Michael Edmond, MD, MPH, MPA. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Henri Verbrugh, MD, PhD, FIDSA. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Allison McGeer, MD, FRCPC. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. Susan Huang, MD, MPH. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
PDF of a PowerPoint presentation by Dr. John Jernigan, MD, MS. Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs)
The 3-day Canadian Consensus Development Conference on Surveillance & Screening for Antimicrobial-Resistant Organisms (AROs) held in Calgary, Alberta from June 18 - 20, 2014, was the first event of its kind to look at issues in the field of AROs.
Congratulations to Dr. Egon Jonsson, winner of the 2014 David Banta Award. Edmonton – Institute of Health Economics’ (IHE) Executive Director and CEO, Egon Jonsson, Ph.D., is the winner of the 2014 “H. David Banta Distinguished Career Award” in the field of health technology assessment (HTA). The award was announced at the meeting of Health Technology…
BACKGROUND: Interest in the impact of burnout on physicians has been growing because of the possible burden this may have on health care systems. The objective of this study is toestimate the cost of burnout on early retirement and reduction in clinical hours of practicingphysicians in Canada.
The objective of this paper is to estimate the additional costs to the criminal justice system associated with people with mental illness who go through the system. The focus of the report is on costs in Alberta.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the potential role of low dose computed tomography (LDCT) in screening for lung cancer in adults aged 50 years or older in Alberta. Section Authors: Section One – Social and System Demographics Analysis: Bing Guo, Dagmara Chojecki Section Two –…
Thursday, 29 May 2014 Edmonton, Alberta The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Key Symposium Documents Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care – Symposium ProgramDownload Program …
Speaker Biographies Dianne Mosher, MD Dr. Dianne Mosher is currently Professor of Medicine and the Chief of the Division of Rheumatology at the University of Calgary. She has practiced Rheumatology for the past twenty years having graduated from Dalhousie Medical School in 1983 where she also completed her Internal Medicine and Rheumatology residency training. Dr. Mosher is a past…
Thursday, 29 May 2014 Edmonton, Alberta Moderator Dianne Mosher, University of Calgary 09:00 – 09:15 Welcome and Opening Remarks Michele Evans, Executive Director, Pharmaceutical Funding and Guidance, Government of Albertahttp://vimeo.com/album/3477664/video/97379108 09:15 – 09:30 Biologic and Biosimilar Therapies - The Changing Landscape of the Management of Rheumatoid…
Symposium Program Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care – Symposium ProgramDownload Program White Paper Rheumatoid Arthritis in a Policy Perspective: A registry for research and better treatment of Albertans – White PaperDownload White Paper
PDF of PowerPoint Presentation by Dr. Dianne Mosher, Chief, Division of Rheumatology, Department of Medicine, University of Calgary. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Liam Martin, Professor, University of Calgary. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Ms. Cheryl Koehn, Founder and President, Arthritis Consumer Experts (ACE). Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Micheal Guirguis, Drug Stewardship Pharmacist, Alberta Health Services (AHS). Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Ms. Suzanne Lepage, Private Health Plan Strategist. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
PDF of a PowerPoint Presentation by Dr. Agnes Klein, Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics at Health Canada, Health Canada. Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium Note: Slide 16 of this presentation contains an error…
PDF of a PowerPoint Presentation by Dr. Chander Sehgal, Director, Common Drug Review (CDR) and Optimal Use, Canadian Agency for Drugs and Technologies in Health (CADTH). Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care Symposium
Biologic and Biosimilar Therapies: The Future of Biologic and Biosimilar Therapies for the Management of Rheumatoid Arthritis in Alberta Health Care.
Speaker Biographies Keynote Speakers Dr. Sube Banerjee MB BS, MSc, MBA, MD, FRC Psych, MBEProfessor & Associate Dean, Brighton and Sussex Medical School Sube Banerjee is Professor of Dementia and Associate Dean for Strategy at Brighton and Sussex Medical School, directing its Centre for Dementia Studies. Clinically he works as an old age psychiatrist in Sussex. He was the Department…
27 May 2014Edmonton, Alberta Welcome and Greetings from the Minister of Health Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/97426151 Keynote presentations Quality of life and quality of care in dementiaDr. Sube Banerjee, Brighton and Sussex Medical SchoolDownload Presentation http://vimeo.com/channels/907291/97466183 Coordinating Care…
27 May 2014 Edmonton, Alberta Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care – FINAL PROGRAMDownload…
Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PDF of a PowerPoint presentation by Dr. Sube Banerjee, Brighton and Sussex Medical School. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. Duncan Robertson, Seniors Health Strategic Clinical Network, Alberta Health Services. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. Carole Estabrooks, University of Alberta. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Mrs. Corinne Schalm, Alberta Health. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
PDF of a PowerPoint presentation by Dr. David C. Grabowski, Harvard Medical School. IHE Innovation Forum XI – Meeting the Challenge: Dementia and Continuing Care
Meeting the Challenge: Dementia and Continuing Care is the 11th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
This informative PowerPoint is publicly available for use as an introductory resource for justice professionals who are seeking an educational tool to assist in group presentations/training regarding involvement of those with Fetal Alcohol Spectrum Disorder (FASD) in the criminal justice system.
Le PowerPoint informative est publiquement disponible pour une utilisation en tant que ressource d'introduction pour les professionnels de la justice qui cherchent un outil pédagogique pour aider à des présentations de groupe / formation concernant la participation de ceux qui ont des troubles causés par l'alcoolisation fœtale (ETCAF ) dans le…
Should vitamin B12 tablets be included in more Canadian drug formularies? An economic model of the cost-saving potential from increased utilisation of oral versus intramuscular vitamin B12 maintenance therapy for Alberta seniors. OBJECTIVE: The aim of this study was to estimate the cost-savings attainable if all patients aged ≥65 years in Alberta, Canada, currently on…
OBJECTIVES: The objective of this study was to explore the degree to which databases otherthan MEDLINE contribute studies relevant for inclusion in rapid health technology assessments (HTA).
This report has been produced in response to a request from Alberta Health (AH). The objective was to perform a review of practices of engaging committees composed of lay people or members of the general public at international, national, provincial, and regional levels. The review attempts to address the following questions: What scientific evidence is available about committees…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September 2013.The Edmonton Charter was drafted by senior staff of…
BACKGROUND: The use of a restrictive formulary, with placement determined through a drug-reimbursement decision-making process, is one approach to managing drug expenditures.
IHE In Your Pocket 2014 – a handbook of health economic statistics includes the most currently available data, presented in separate sections on the economic burden of illness, health care resources, health behaviours, health status and demographics, and health system performance. IHE In Your Pocket was designed to provide a compact, comprehensive, and comparative overview…
BACKGROUND: Pay-for-performance (P4P) is increasingly touted as a means to improve health care quality. PURPOSE: To evaluate the effect of P4P remuneration targeting individual health careproviders.
Speaker Biographies Keynote Speaker Mr. Don DrummondFormer Senior Vice President and Chief Economist, TD Bank Financial Group Don Drummond is the former Senior Vice President and Chief Economist at TD Financial Group. He retired from TD to his current role as Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University. Prior to joining…
6 December 2012Edmonton, Alberta Introductory Remarks – Government of Alberta Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/56013748 Keynote Presentation Mr. Don Drummond, Former Senior Vice President and Chief Economist, TD Bank Financial Grouphttp://vimeo.com/channels/907291/56036522 Panel Discussion ModeratorDr. Annette Trimbee,…
6 December 2012 Edmonton, Alberta Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President…
Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President and Chief Economics at TD Financial…
Value for Money in the Health System was the eighth in the series of Innovation Forums. The keynote speaker, Mr. Don Drummond, Matthews Fellow and Distinguished Visiting Scholar in the School of Policy Studies at Queens University, and a former Associate Deputy Minister of Finance in the Government of Canada, as well as a former Senior Vice President and Chief Economics at TD Financial…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report performs an evaluation of the scientific evidence on the safety, performance, and effectiveness of universal and targeted preschool hearing screening (PHS) to inform the Infant and Preschool Screening Framework being developed by the Community and Public Health (CPH)…
Stroke Prevention and Management in Primary Care: a free forum at the 2012 Accelerating Primary Care Conference Sunday, 18 November 2012 Fairmont Banff Springs Hotel, Banff, Alberta Stroke Update 2012 was a free forum for primary care clinicians, held in conjunction with the annual Accelerating Primary Care conference in Banff, Alberta, November 18, 2012. The forum brought together…
Stroke Update 2012 was a free forum for primary care clinicians, held in conjunction with the annual Accelerating Primary Care conference in Banff, Alberta, November 18, 2012. The forum brought together 5 physician leaders to review the current “state of the art” in the rapidly advancing field of stroke prevention and care, with an emphasis on the role of primary care.…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This review focused on the best evidence available on the use of PSVS to detect vision conditions in asymptomatic preschool children (aged from birth to 6 years; not necessarily considered at risk for developing visual impairment) to determine the safety and efficacy/effectiveness…
The EQ-5D is a standardized instrument developed by the EuroQol group for use as a measure of health outcome. It considers five dimensions of health-related quality of life: mobility, self-care, usual activities, pain/discomfort, anxiety/depression. When the need for greater collaboration around implementation and use of the EQ-5D in Alberta was recognized in eary 2012, colleagues…
18 – 19 October 2012 Canmore, Alberta The EQ-5D is a standardized instrument developed by the EuroQol group for use as a measure of health outcome. It considers five dimensions of health-related quality of life: mobility, self-care, usual activities, pain/discomfort, anxiety/depression. When the need for greater collaboration around implementation and use of the EQ-5D in…
Biographies Stirling Bryan National Institute for Health and Clinical Excellence (NICE) Experience with Using the EQ-5D in Economic Analysis Dr. Stirling Bryan is a professor in UBC's School of Population & Public Health, and Director of the Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute. Dr. Bryan is an economist with a career-long…
Thurs 18 Oct 2012 | Fri 19 Oct 2012 Thursday, 18 October 2012 08:45 – 09:00 Welcome and Opening Remarks Charlene McBrien-Morrison, Executive Director, Health Quality Council of Alberta Steve Buick, Director of Policy and Communications, Institute of Health Economics Kathryn Todd, Senior Vice President, Research, Alberta Health Services 09:00 – 09:30 EQ-5D - Building…
Symposium Proceedings Patient-Reported Outcomes Measurement in Alberta: Potential of the EQ-5D SYMPOSIUM PROCEEDINGS Download Symposium Proceedings
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of a 2007 report. Permanent congenital hearing impairment/loss (PCHI/PCHL) is one of the most common congenital anomalies found at birth which can lead to delays and deficits in the development of speech, language, cognition, and learning, as well as…
This project is concerned with describing a comprehensive set of HTA products, not the methods used to produce them. The report describes various products produced by HTA agencies and provides a summary of the basic elements of these products, but an in-depth analysis of, or comparison between, the various products in terms of their methodology is beyond its scope. Information…
Background: The aim of this study was to extend an earlier retrospective cohort study of schizophrenia via a prospective study to a follow-up of 34 years, with an emphasis on describing the life-course of the illness.
Background: The benefits of pharmaceutical innovations are widely diffused; they accrue to the healthcare providers, patients, employers, and manufacturers. We estimate the societal monetary benefits of simvastatin in Canada and its distribution among different beneficiaries overtime.
OBJECTIVES: In Canada, most mental health services are embedded in the publichealth care system. Little is known of the cost distribution within the mental healthpopulation. Our study aims to estimate the depression care costs of patients with adepression diagnosis, ranking them by the increasing total depression health carecosts.
Abstract: The potential risks to patient safety in a primary care setting are different than the risks to patient safety in an acute care setting. The main differences arise from the organisational structures of primary care delivery and the greater involvement of patients in their care. To account for these differences, we present the Patient Safety in Primary Care Framework…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report provides an epidemiological profile of fetal aneuploidy and open neural tube defects (ONTD); describes the patterns of care, utilization trends, and factors affecting the provision of first and second trimester screening (FASTs) services for fetal aneuploidy and…
30 July 2012 Montréal, Québec The concept of “personalized medicine” in health is garnering increased attention. Personalized medicine can be defined as the tailoring of preventive, diagnostic, or therapeutic interventions to the characteristics of an individual or population. This may involve genetic or laboratory biomarker information. As personalized…
Monday, 30 July 2012Montréal, Québec Welcome, Introductions, and Overview John Sproule, IHEDon Husereau, University of Ottawa Roundtable Discussion – Assessment of System Readiness Moderator: John Sproule Is the current state of adoption and implementation ideal? What should the goals be for personalized medicine in Canada? What are the components of a vision…
Final Report Personalized Medicine – Policy Gaps and System Readiness: Summary Report of Roundtable Discussion Download Final Report
This background document outlines the methods used to update the Alberta Clinical Practice Guideline (CPG) for the Evidence-Informed Primary Care Management of Low Back Pain, which was produced as part of the second phase of the Alberta Health Technology Assessment (HTA) Ambassador Program. Link to Alberta Ambassador Guideline Adaptation Program
For which strategies of suicide prevention is there evidence of effectiveness? This report aims to synthesize research findings from existing systematic reviews to address two questions: What types of preventive interventions have been evaluated in the published literature? Which strategies have good-quality evidence to support them? Limited evidence - as well as variability by…
The concept of “personalized medicine” in health is garnering increased attention. Personalized medicine can be defined as the tailoring of preventive, diagnostic, or therapeutic interventions to the characteristics of an individual or population. This may involve genetic or laboratory biomarker information. As personalized medicine promises to increasingly change the…
Primary Care Management of Headache in Adults1st edition, July 2012Guideline Documents including Full Guideline (Hosted by Towards Optimized Practice (TOP) Alberta) The guideline was developed as part of the Alberta Ambassador Guideline Adaptation Program (http://www.ihe.ca/research-programs/hta/aagap)
STUDY OBJECTIVE: To quantify the potential cost savings of a community pharmacy-basedhypertension management program based on the results of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN) study in terms of avoided cardiovascular events-myocardial infarction, stroke, and heart failure hospitalization, and to compare these cost savings…
31 May 2012 Edmonton, Alberta Social Determinants of Health is the seventh IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Key Forum Documents Innovation Forum VII – Social Determinants of Health – FINAL PROGRAMDownload Final Program
Speaker Biographies Keynote Speaker Sir Michael MarmotDirector, Institute of Health Equity and MRC Research Professor in Epidemiology, University College London Sir Michael Marmot has led a research group on health inequalities for the past 30 years. He has been invited by the Regional Director of WHO Euro to conduct a European review of health inequalities. At the request of the…
31 May 2012Edmonton, Alberta Welcome and Introductions Dr. Lorne Tyrrell, Chair, Institute of Health EconomicsDownload Presentation http://vimeo.com/channels/907291/44105094 Dr. Chris Mazurkewich, Executive Vice President and CEO, Alberta Health Serviceshttp://vimeo.com/channels/907291/45175125 Honourable David Hancock, Minister of Human Serviceshttp://vimeo.com/channels/907291/44087423 …
PDF of a PowerPoint presentation by Dr. Lorne Tyrrell, Chair, Institute of Health Economics. IHE Innovation Forum VII – Social Determinants of Health
PDF of a PowerPoint presentation by Sir Michael Marmot, Director, Institute of Health Equity and MRC Research Professor in Epidemiology, University College London. IHE Innovation Forum VII – Social Determinants of Health
Social Determinants of Health is the seventh IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues.
PURPOSE: This longitudinal study assessed the changes in drug use patterns and health-related quality of life (HRQL) among HIV-positive drug users in the first methadonemaintenance treatment (MMT) cohort in Vietnam.
This exploratory report provides a summary of some of the published information on the current status of research in and potential future sphere of activity of nanomedicine (Part I) and an inventory of resources on nanotechnology and nanomedicine (Part II). Over the next 5 to 10 years it is expected that the overall impact of nanomedicine will be multifaceted, with significant…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report summarizes available key information on the use of bariatric treatments for adult obesity in Alberta and North America (mainly Canada). This analysis was intended to describe the profile of adult obesity (definition, progression, epidemiology, and population dynamics…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report examines the research evidence on the safety and efficacy of insulin pump therapy, as compared to multiple daily insulin injections, in the treatment of children, adults, and pregnant women diagnosed with type 1 diabetes. The report also analyses the economic impact…
This Methodology Paper summarizes the process, a modified Delphi approach, used to develop a specific checklist for the quality appraisal of case series studies. This work was supplemented with a review of other published checklists and an initial pilot test of the newly developed quality appraisal checklist. Researchers at the Institute of Health Economics with researchers from…
OBJECTIVES: The recent emphasis on knowledge translation (KT) in health care is based on the premise that quality of care improves when research findings are translated into practice. This study aimed to identify the extent, nature, and settings of KT research pertaining to the care of older adults.
This report describes a framework for evaluating policies developed within the Alberta Health Technologies Decision Process (AHTDP) to strengthen the link between policy development and evidence. The framework was designed as a foundation upon which to build a more detailed and contextualized evaluative process in consultation with all stakeholders who are likely to be affected…
In February 2012, the Canadian Institute for Health Information (CIHI) in partnership with the Institute of Health Economics (IHE) sponsored a two day meeting of content, administrative and research experts to identify the breadth of diagnostic imaging studies that CIHI might feasibly undertake with its data or with data that could be easily obtained. The purpose of this report…
Sponsored by the Institute of Health Economics (IHE) – Methodology Forum Series. Presented at the Health Canada and Canadian Institutes of Health Research Personalised Medicine in Canada: A Multi-Stakeholder Workshop to Examine the Canadian Perspective, January 12, 2012. The specific objectives of this session/workshop were to: Explore issues relevant to economic evaluation…
Aim: To critically appraise the clinical research evidence on the safety and effectiveness of FT compared with standard care in the treatment of patients with CDAD.
Final Summary CIHI/IHE Diagnostic Imaging Invitational Workshop – Meeting SummaryDownload Meeting Summary
6 – 7 February 2012 Edmonton, Alberta As part of the Alberta Ambassador Guideline Adaptation Program, in February 2012, the Canadian Institute for Health Information (CIHI) in partnership with the Institute of Health Economics (IHE) sponsored a two day meeting of content, administrative and research experts to identify the breadth of diagnostic imaging studies that CIHI might…
From the Introduction: Until four or five decades ago, the clinical consensus about childhood depression was that it did not, and perhaps could not, occur (Lefkowitz & Burton, 1978; Rie, 1966; Rochlin, 1965; Wolfenstein, 1966). In fact, prior to 1960, childhood depression was rarely mentioned in the literature (Cytryn, 2003; Tisher, 2007). A number of studies and conceptualizations…
11 – 12 January 2012 Ottawa, Ontario The IHE has established a series of methodologic forums with the intent of identifying and addressing major methodological challenges in informing policies and decisions around the funding and use of health technologies, in partnership with its private and public stakeholders that are involved in the production of evidence and use of assessment.…
Speakers Dr. Jeffrey Hoch Associate Professor, Department of Health Policy, Management and Evaluation, University of Toronto; Director Pharmacoeconomics Research Unit, Cancer Care Ontario Dr. Stuart Peacock Associate Professor, School of Population and Public Health, University of British Columbia; Co-Director, Canadian Centre for Applied Research in Cancer Control Mr. Don Husereau…
Wednesday – Thursday, 11 – 12 January 2012Ottawa, Ontario Selected Plenary Presentations from Health Canada/CIHR Workshop Measuring Value in Personalized MedicineDr. Deborah Marshallhttp://player.vimeo.com/video/35735037 HTA Assessment in Australia - Challenges for Personalized MedicineDr. Robyn Wardhttp://player.vimeo.com/video/35785570 Stratified Medicine - Observations…
Final Report IHE Methodology Forum: Personalized Medicine – Research Challenge – Health Economics Methodology Forum Summary Download Final Report
This study measures the return on investment for parent training at the pre- or early childhood stage. The purpose is to prevent conduct disorders in childhood, and mental health problems in adolescence and adulthood. The program studied is the Triple P program. The context is a one year birth cohort in Alberta. The costs are for a universal parental training program. The downstream…
